Stonepine Capital Management Expands CalciMedica Stake in Bold Contrarian Move

gurufocus.com · 2026-09-01

On Aug. 19, 2026, Stonepine Capital Management, LLC (Trades, Portfolio) made a notable addition to its position in CalciMedica Inc (NASDAQ:CALC), acquiring 305,

TickrTrends take: ADMA Biologics operates in the Healthcare sector where strategic investor moves can signal confidence in underlying asset valuations. Stonepine Capital Management's expansion of its CalciMedica stake represents a contrarian positioning that reflects investor conviction in healthcare opportunities that may not yet be fully recognized by broader markets. For valuation-focused readers tracking ADMA, such moves within the Healthcare investment landscape underscore the importance of monitoring institutional positioning as a potential indicator of whether current market prices adequately reflect future potential.

Read the full story at gurufocus.com →